We’re excited to see that Medicines for All Institute, having delivered huge improvements in affordability and access to a wide range of global health treatments, is now moving to secure the supply chains for essential medications in the USA. We’re very proud that Frank Gupton asked Bruce to help him prepare the original business plan for M4ALL, seek […]
M4ALL Securing the Pharma Supply Chain
Research Article: Using electronic medication monitoring to guide differential management of tuberculosis patients at the community level in China
We were thrilled to support this important and successful evaluation of medication monitors to support the care of self-administering TB patients.
Stop TB Partnership Virtual Innovation Spotlights
top TB Partnership is hosting a series of “virtual innovation spotlights” to highlight promising technologies for better TB care. The first session on Qure.ai from our friend, Prashant Warier, will talk about how we can leverage AI for screening, contact tracing, and triaging for TB and COVID-19.
Launch of the Re-imagining TB Care Website
The Arcady Group is proud to have supported the Stop TB Partnership’s vision in transforming care models in high TB burden countries by creating the Re-imagining TB Care website.
Evaluation Team Lead for IDAT for Treatment Support of TB Patients
I was honored to be invited by USAID (Dr. Amar Shah) and the WHO (Dr. Malik Parmar) to serve as Mewat Evaluation Team Leader for India’s Evaluation of Integrated Digital Adherence Technology (IDAT) For Treatment Support of TB Patients. Our team [Mr. Bruce Thomas (lead), Dr. Shanker Matta, Mr. Bharat Bhushan Dahiya, Dr. Bhavin Vadera, Dr. Srikrishna S R, Dr. Yogesh Gurav, Dr. […]
Stop TB Award
We are honored and thrilled that the Stop TB Partnership’s Strategic Initiatives and Innovative Financing (“SIIF”) team has selected The Arcady Group to provide consulting services to accelerate the roll-out of emerging technologies and digital health solutions to End TB.
More adherence support for self-administering TB patients is on the way!
Unitaid and the KNCV Tuberculosis Foundation signed a US$13.9 million grant agreement to enhance the existing evidence base, drive scaled deployment, and create market access plans and tools for digital adherence technologies to enhance TB medication adherence.
- 1
- 2
- 3
- 4
- Next Page »
